Literature DB >> 12446255

Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies.

Nina S Godtfredsen1, Claus Holst, Eva Prescott, Jørgen Vestbo, Merete Osler.   

Abstract

The authors investigated the association between changes in smoking habits and mortality by pooling data from three large cohort studies conducted in Copenhagen, Denmark. The study included a total of 19,732 persons who had been examined between 1967 and 1988, with reexaminations at 5- to 10-year intervals and a mean follow-up of 15.5 years. Date of death and cause of death were obtained by record linkage with nationwide registers. By means of Cox proportional hazards models, heavy smokers (>or=15 cigarettes/day) who reduced their daily tobacco intake by at least 50% without quitting between the first two examinations and participants who quit smoking were compared with persons who continued to smoke heavily. After exclusion of deaths occurring in the first 2 years of follow-up, the authors found the following adjusted hazard ratios for subjects who reduced their smoking: for cardiovascular diseases, hazard ratio (HR) = 1.01 (95% confidence interval (CI): 0.76, 1.35); for respiratory diseases, HR = 1.20 (95% CI: 0.70, 2.07); for tobacco-related cancers, HR = 0.91 (95% CI: 0.63, 1.31); and for all-cause mortality, HR = 1.02 (95% CI: 0.89, 1.17). In subjects who stopped smoking, most estimates were significantly lower than the heavy smokers'. These results suggest that smoking reduction is not associated with a decrease in mortality from tobacco-related diseases. The data confirm that smoking cessation reduces mortality risk.

Entities:  

Mesh:

Year:  2002        PMID: 12446255     DOI: 10.1093/aje/kwf150

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Burden of smoking on cause-specific mortality: application to the Nurses' Health Study.

Authors:  Stacey A Kenfield; Esther K Wei; Bernard A Rosner; Robert J Glynn; Meir J Stampfer; Graham A Colditz
Journal:  Tob Control       Date:  2010-06       Impact factor: 7.552

3.  The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan.

Authors:  C P Wen; T Y Cheng; C-L Lin; H-N Wu; D T Levy; L-K Chen; C-C Hsu; M P Eriksen; H-J Yang; S P Tsai
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

Review 4.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

Review 5.  Managing smoking cessation.

Authors:  Paul Aveyard; Robert West
Journal:  BMJ       Date:  2007-07-07

6.  Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.

Authors:  D F Heitjan; D A Asch; Riju Ray; Margaret Rukstalis; Freda Patterson; C Lerman
Journal:  Pharmacogenomics J       Date:  2008-03-18       Impact factor: 3.550

7.  How should we define light or intermittent smoking? Does it matter?

Authors:  Corinne G Husten
Journal:  Nicotine Tob Res       Date:  2009-02-20       Impact factor: 4.244

8.  A computerized aid to support smoking cessation treatment for hospital patients.

Authors:  Kate E Koplan; Susan Regan; Robert C Goldszer; Louise I Schneider; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2008-05-09       Impact factor: 5.128

9.  Age Differences in the Trends of Smoking Among California Adults: Results from the California Health Interview Survey 2001-2012.

Authors:  Yue Pan; Weize Wang; Ke-Sheng Wang; Kevin Moore; Erin Dunn; Shi Huang; Daniel J Feaster
Journal:  J Community Health       Date:  2015-12

10.  Life Years Gained From Smoking-Cessation Counseling After Myocardial Infarction.

Authors:  Emily M Bucholz; Adam L Beckman; Catarina I Kiefe; Harlan M Krumholz
Journal:  Am J Prev Med       Date:  2016-09-28       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.